Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis.

I-Hsin HuangPo-Chien WuHsien-Yi ChiuYu-Huei Huang

Published in: American journal of clinical dermatology (2024)

Among all available biologics and small-molecule inhibitors, secukinumab 300 mg and guselkumab 100 mg had the most favorable efficacy in treating PP and PPP, respectively.

Keyphrases

small molecule
protein protein
ankylosing spondylitis
rheumatoid arthritis
systemic lupus erythematosus